InvestorsHub Logo
Followers 47
Posts 5250
Boards Moderated 0
Alias Born 01/27/2012

Re: falconer66a post# 159702

Wednesday, 07/25/2018 6:10:05 PM

Wednesday, July 25, 2018 6:10:05 PM

Post# of 464094

If there are 5.5 million Americans with Alzheimer’s, Anavex will be able to treat only 80% of those, about 4.4 million.



How many of the 80% of those patients when they hear that there is a new safe effective drug with symptomatic relief for Alz will not want to try it......IMMEDIATELY! Hell I might even want to try the drug even if I wasnt want one that responded from the biomarker sample.

Early approval in ph 2/3 Au AD trial working for %80 of the AD population with a targeted drug proven to work will equate to a massive market share very FAST! If the FDA wants to sit on its hands so be it. I wouldnt want to be in the HHS or answer Gottliebs phone when this comes home to roost.

Dont sell cheap my fellow longs, you have/are being set up for an early sell out due to frustration. The MM's are pressure cooking this stock price. The buy back in may cause some side effects listed but not limited to:

"upper respiratory tract infection, abnormal dreams and nightmares, contact dermatitis, headache, diarrhea, and falls."

Tred
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News